The formation of the pre-B cell receptor (BCR) corresponds to an important checkpoint in B cell development that selects pro-B (pre-BI) cells expressing a functionally rearranged immunoglobulin μ (Igμ) heavy chain protein to undergo the transition to the pre-B (pre-BII) cell stage. The pre-BCR contains, in addition to Igμ, the surrogate light chains λ5 and VpreB and the signal transducing proteins Igα and Igβ. The absence of one of these pre-BCR components is known to arrest B cell development at the pre-BI cell stage. Disruption of the Pax5 gene, which codes for the B cell–specific activator protein (BSAP), also blocks adult B lymphopoiesis at the pre-BI cell stage. Moreover, expression of the mb-1 (Igα) gene and VH-to-DHJH recombination at the IgH locus are reduced in Pax5-deficient B lymphocytes ∼10- and ∼50-fold, respectively. Here we demonstrate that complementation of these deficiencies in pre-BCR components by expression of functionally rearranged Igμ and chimeric Igμ-Igβ transgenes fails to advance B cell development to the pre-BII cell stage in Pax5 (−/−) mice in contrast to RAG2 (−/−) mice. Furthermore, the pre-BCR is stably expressed on cultured pre-BI cells from Igμ transgenic, Pax5-deficient bone marrow, but is unable to elicit its normal signaling responses. In addition, the early developmental block is unlikely to be caused by the absence of a survival signal, as it could not be rescued by expression of a bcl2 transgene in Pax5-deficient pre-BI cells. Together, these data demonstrate that the absence of Pax5 arrests adult B lymphopoiesis at an early developmental stage that is unresponsive to pre-BCR signaling.
Skip Nav Destination
Article navigation
17 August 1998
Article|
August 17 1998
Early Function of Pax5 (BSAP) before the Pre-B Cell Receptor Stage of B Lymphopoiesis
Claire Thévenin,
Claire Thévenin
From the Research Institute of Molecular Pathology, A-1030 Vienna, Austria
Search for other works by this author on:
Stephen L. Nutt,
Stephen L. Nutt
From the Research Institute of Molecular Pathology, A-1030 Vienna, Austria
Search for other works by this author on:
Meinrad Busslinger
Meinrad Busslinger
From the Research Institute of Molecular Pathology, A-1030 Vienna, Austria
Search for other works by this author on:
Claire Thévenin
From the Research Institute of Molecular Pathology, A-1030 Vienna, Austria
Stephen L. Nutt
From the Research Institute of Molecular Pathology, A-1030 Vienna, Austria
Meinrad Busslinger
From the Research Institute of Molecular Pathology, A-1030 Vienna, Austria
Address correspondence to Meinrad Busslinger, Research Institute of Molecular Pathology, Dr. Bohr-Gasse 7, A-1030 Vienna, Austria. Phone: 43-1-797-30-452; Fax: 43-1-798-71-53; E-mail: [email protected]
Claire Thévenin's present address is Department of Medical and Molecular Parasitology, New York University Medical Center, New York, NY 10016.
Received:
April 08 1998
Revision Received:
June 09 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (4): 735–744.
Article history
Received:
April 08 1998
Revision Received:
June 09 1998
Citation
Claire Thévenin, Stephen L. Nutt, Meinrad Busslinger; Early Function of Pax5 (BSAP) before the Pre-B Cell Receptor Stage of B Lymphopoiesis . J Exp Med 17 August 1998; 188 (4): 735–744. doi: https://doi.org/10.1084/jem.188.4.735
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement